Pink eye treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
219
NCT03856645
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 11, 2019
Completion: Jun 30, 2022
Loading map...